303 related articles for article (PubMed ID: 33517446)
21. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube GK; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Pinheiro SVB; Oliveira EA; Simoes E Silva AC; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
Nat Commun; 2023 Nov; 14(1):7836. PubMed ID: 38036523
[TBL] [Abstract][Full Text] [Related]
22. Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Results From the Chronic Kidney Disease in Children (CKiD) Cohort.
Durand A; Winkler CA; Vince N; Douillard V; Geffard E; Binns-Roemer E; Ng DK; Gourraud PA; Reidy K; Warady B; Furth S; Kopp JB; Kaskel FJ; Limou S
Am J Kidney Dis; 2023 Jun; 81(6):635-646.e1. PubMed ID: 36623684
[TBL] [Abstract][Full Text] [Related]
23. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
[TBL] [Abstract][Full Text] [Related]
24. APOL1 risk variants and the development of HIV-associated nephropathy.
Goyal R; Singhal PC
FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
[TBL] [Abstract][Full Text] [Related]
25.
Zhang JY; Wang M; Tian L; Genovese G; Yan P; Wilson JG; Thadhani R; Mottl AK; Appel GB; Bick AG; Sampson MG; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3446-3451. PubMed ID: 29531077
[TBL] [Abstract][Full Text] [Related]
26. APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice.
Ryu JH; Ge M; Merscher S; Rosenberg AZ; Desante M; Roshanravan H; Okamoto K; Shin MK; Hoek M; Fornoni A; Kopp JB
PLoS One; 2019; 14(4):e0211559. PubMed ID: 30998685
[TBL] [Abstract][Full Text] [Related]
27. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.
Yang YW; Poudel B; Frederick J; Dhillon P; Shrestha R; Ma Z; Wu J; Okamoto K; Kopp JB; Booten SL; Gattis D; Watt AT; Palmer M; Aghajan M; Susztak K
Mol Ther; 2022 Jul; 30(7):2491-2504. PubMed ID: 35450819
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.
Gupta N; Waas B; Austin D; De Mazière AM; Kujala P; Stockwell AD; Li T; Yaspan BL; Klumperman J; Scales SJ
Sci Rep; 2024 Feb; 14(1):3765. PubMed ID: 38355600
[TBL] [Abstract][Full Text] [Related]
29. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
30. Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.
Ekulu PM; Adebayo OC; Decuypere JP; Bellucci L; Elmonem MA; Nkoy AB; Mekahli D; Bussolati B; van den Heuvel LP; Arcolino FO; Levtchenko EN
Cells; 2021 Jul; 10(8):. PubMed ID: 34440683
[TBL] [Abstract][Full Text] [Related]
31. A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis.
McNulty MT; Fermin D; Eichinger F; Jang D; Kretzler M; Burtt NP; Pollak MR; Flannick J; Weins A; Friedman DJ; ; Sampson MG
Kidney Int; 2022 Jul; 102(1):136-148. PubMed ID: 34929253
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
33. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
[TBL] [Abstract][Full Text] [Related]
34. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress.
Wakashin H; Heymann J; Roshanravan H; Daneshpajouhnejad P; Rosenberg A; Shin MK; Hoek M; Kopp JB
BMC Nephrol; 2020 Aug; 21(1):371. PubMed ID: 32854642
[TBL] [Abstract][Full Text] [Related]
35. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
[TBL] [Abstract][Full Text] [Related]
36. Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunity.
Karttunen H; Ross MJ
Kidney Int; 2023 Aug; 104(2):230-233. PubMed ID: 37224919
[No Abstract] [Full Text] [Related]
37. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
38. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
39. Pathobiology of focal segmental glomerulosclerosis: new developments.
D'Agati VD
Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
[TBL] [Abstract][Full Text] [Related]
40. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
